Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy
Yang Liu,1 Zhengyuan Zhou,2 Yutian Feng,2 Xiao-Guang Zhao,2 Ganesan Vaidyanathan,2 Michael R Zalutsky,1,2 Tuan Vo-Dinh1,3,4 1Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA; 2Department of Radiology, Duke University Medical Center, Durham, NC, 27710, USA; 3Department of...
Guardado en:
Autores principales: | Liu Y, Zhou Z, Feng Y, Zhao XG, Vaidyanathan G, Zalutsky MR, Vo-Dinh T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d2911eaef9b4861bfe2d09d6ac7c17e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars
por: Crawford BM, et al.
Publicado: (2017) -
Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy
por: Si Chen, et al.
Publicado: (2021) -
Enhancing the Therapeutic Effect of 2-<sup>211</sup>At-astato-α-methyl-L-phenylalanine with Probenecid Loading
por: Hirofumi Hanaoka, et al.
Publicado: (2021) -
Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars
por: Liu Y, et al.
Publicado: (2019) -
Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging
por: D’Hollander A, et al.
Publicado: (2016)